Multiple Sclerosis Discovery Forum

Inspiring Connections

Utility Navigation

User Top Menu


DMT Discontinuation Review Stirs MS Research Community

Daniel Kantor
The U.S. Agency for Healthcare Research and Quality (AHRQ) recently released a draft review on the evidence on discontinuation of disease-modifying therapies. Shocked by the apparent lack of expertise in the first draft, MS researchers and advocacy groups sent in a wave of comments chastising the AHRQ for the perceived shoddiness of the report.
A draft review of the evidence surrounding discontinuation of disease-modifying therapies has sparked...
Clinical Research, Methods

MS Research Roundup: October 3, 2014

Research Roundup logo
Stem Cells Pass Safety Trials; Generic Similar to Copaxone; Epigenetic Differences in Monocytes and Macrophages; One Brain, Many Genomes
Items of interest to multiple sclerosis researchers from around the Web...
Clinical Research, Drug Development, Laboratory Research, Methods


Subscribe to RSS - Methods